KAG-308 from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
KAG-308

Get Pricing

Description

KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration